Latest filing published 15 Jun 2026 for Biocryst Pharmaceuticals INC. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Filings by Alan G. Levin span 2 companies, the busiest being Biocryst Pharmaceuticals Inc and CervoMed Inc. Over a trading history stretching from 8 January 2016 to 11 June 2026, the count stands at 15 filings.
The open-market record is one-sided, with 1 purchase worth €46k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 14 share grants.
Most recently, on 15 June 2026, the filings show a share grant in Biocryst Pharmaceuticals Inc. The clock since the last published purchase (31 May 2024) now reads 870 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
15 of 15 declarations